[go: up one dir, main page]

CL2013000099A1 - A method of increasing the effect of an potentiated active form of an antibody to an endogenous biological molecule, comprising the combination of the endogenous biological molecule with an enhanced active form of an endoltelial non-synthase antibody; composition that understands it. - Google Patents

A method of increasing the effect of an potentiated active form of an antibody to an endogenous biological molecule, comprising the combination of the endogenous biological molecule with an enhanced active form of an endoltelial non-synthase antibody; composition that understands it.

Info

Publication number
CL2013000099A1
CL2013000099A1 CL2013000099A CL2013000099A CL2013000099A1 CL 2013000099 A1 CL2013000099 A1 CL 2013000099A1 CL 2013000099 A CL2013000099 A CL 2013000099A CL 2013000099 A CL2013000099 A CL 2013000099A CL 2013000099 A1 CL2013000099 A1 CL 2013000099A1
Authority
CL
Chile
Prior art keywords
active form
biological molecule
antibody
endogenous biological
endoltelial
Prior art date
Application number
CL2013000099A
Other languages
Spanish (es)
Inventor
Oleg Lliich Epshtein
Original Assignee
Epshtein Oleg Iliich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53404976&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013000099(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010129298/15A external-priority patent/RU2526153C2/en
Priority claimed from RU2010129291/15A external-priority patent/RU2525156C2/en
Priority claimed from RU2010129295/15A external-priority patent/RU2531049C2/en
Priority claimed from RU2010129294/15A external-priority patent/RU2542414C2/en
Priority claimed from RU2010129292/15A external-priority patent/RU2523557C2/en
Priority claimed from RU2010129290/15A external-priority patent/RU2525155C2/en
Priority claimed from RU2010130353/15A external-priority patent/RU2542445C2/en
Priority claimed from RU2010130358/15A external-priority patent/RU2519695C2/en
Priority claimed from RU2010130356/15A external-priority patent/RU2542453C2/en
Priority claimed from RU2010130355/15A external-priority patent/RU2530638C2/en
Priority claimed from RU2010130348/15A external-priority patent/RU2531048C2/en
Priority claimed from RU2011110106/15A external-priority patent/RU2523451C2/en
Priority claimed from RU2011127051/15A external-priority patent/RU2509572C2/en
Priority claimed from RU2011127055/15A external-priority patent/RU2536230C2/en
Priority claimed from RU2011127058/15A external-priority patent/RU2536232C2/en
Priority claimed from RU2011127059/15A external-priority patent/RU2536234C2/en
Priority claimed from RU2011127053/15A external-priority patent/RU2565400C2/en
Application filed by Epshtein Oleg Iliich filed Critical Epshtein Oleg Iliich
Publication of CL2013000099A1 publication Critical patent/CL2013000099A1/en

Links

CL2013000099A 2010-07-15 2013-01-10 A method of increasing the effect of an potentiated active form of an antibody to an endogenous biological molecule, comprising the combination of the endogenous biological molecule with an enhanced active form of an endoltelial non-synthase antibody; composition that understands it. CL2013000099A1 (en)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
RU2010129291/15A RU2525156C2 (en) 2010-07-15 2010-07-15 Method of treatment and prevention of arterial hypertension and pharmaceutical composition for treatment of arterial hypertension
RU2010129295/15A RU2531049C2 (en) 2010-07-15 2010-07-15 Therapeutic agent for treating prostatic diseases and method of treating prostatic diseases
RU2010129294/15A RU2542414C2 (en) 2010-07-15 2010-07-15 Medication for treating erectile dysfunctions and method of treating erectile dysfunctions
RU2010129292/15A RU2523557C2 (en) 2010-07-15 2010-07-15 Method of treating vegetovascular dystonia and pharmaceutical composition for treating vegetovascular dystonia
RU2010129290/15A RU2525155C2 (en) 2010-07-15 2010-07-15 Method of treating chronic heart failure and pharmaceutical composition for complex therapy of chronic heart failure
RU2010129298/15A RU2526153C2 (en) 2010-07-15 2010-07-15 Method for increase of pharmacological activity of active agent of drug preparation and pharmaceutical composition
RU2010130358/15A RU2519695C2 (en) 2010-07-21 2010-07-21 Medication for treating attention deficit disorder and method of treating attention deficit disorder
RU2010130356/15A RU2542453C2 (en) 2010-07-21 2010-07-21 Therapeutic agent and method of treating vegetative-vascular dystonia, dizziness syndrome of various origins, and kinetosis
RU2010130353/15A RU2542445C2 (en) 2010-07-21 2010-07-21 Medication for treating alzheimer's disease and method of treating alzheimer's disease
RU2010130355/15A RU2530638C2 (en) 2010-07-21 2010-07-21 Medication and method of treating organic diseases of nervous system, psychoorganic syndrome and encephalopathies of different genesis
RU2010130348/15A RU2531048C2 (en) 2010-07-21 2010-07-21 Drug substance for reducing insulin resistance and treating diabetes mellitus and method for providing higher therapeutic effectiveness in diabetes mellitus with insulin and/or antihyperglycemic medications
RU2011110106/15A RU2523451C2 (en) 2011-03-17 2011-03-17 Method of treating chronic cardiac failure and pharmaceutical composition for treating chronic cardiac failure
RU2011127051/15A RU2509572C2 (en) 2011-07-01 2011-07-01 Drug for reducing insulin resistance and for treating diabetes, method of reducing insulin resistance, method of treating diabetes and method of treating diabetes with insulin and/or hypoglycemic preparations
RU2011127055/15A RU2536230C2 (en) 2011-07-01 2011-07-01 Therapeutic agent for treating neurological behaviour disorders and method of treating neurological behaviour development disorders
RU2011127058/15A RU2536232C2 (en) 2011-07-01 2011-07-01 Therapeutic agent for alzheimer's disease and method of treating alzheimer's disease
RU2011127059/15A RU2536234C2 (en) 2011-07-01 2011-07-01 Neurotropic drug and method of treating structural diseases of nervous system, psychoorganic syndrome and encephalopathies of various origins
RU2011127053/15A RU2565400C2 (en) 2011-07-01 2011-07-01 Medication for treating genitourinary system diseases and method of treating genitourinary system diseases

Publications (1)

Publication Number Publication Date
CL2013000099A1 true CL2013000099A1 (en) 2015-01-16

Family

ID=53404976

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013000099A CL2013000099A1 (en) 2010-07-15 2013-01-10 A method of increasing the effect of an potentiated active form of an antibody to an endogenous biological molecule, comprising the combination of the endogenous biological molecule with an enhanced active form of an endoltelial non-synthase antibody; composition that understands it.

Country Status (1)

Country Link
CL (1) CL2013000099A1 (en)

Similar Documents

Publication Publication Date Title
PT4152749T (en) SAMPLE MATRIX CODING FOR LOW DELAY
BR112012002608A2 (en) lubricant composition, and method for improving the performance of a lubricant composition.
CL2013001196A1 (en) Composition comprising a molecule derived from pyridine; process comprising the application of said composition for pest control
DK2651436T3 (en) MYCOBACTERY ANTIGEN COMPOSITION.
BR112014007649A2 (en) structuring material and method for the treatment of an underground formation
BR112014007619A2 (en) cosmetic composition, and method for enhancing at least one property
BR112013006817A2 (en) method, bushing and bushing formed by the method
EP2758355A4 (en) RESIN MATERIALS GEOPOLYMERS, GEOPOLYMER MATERIALS AND MATERIALS OBTAINED THEREFROM
BRPI0817473A2 (en) application platform to run applications
BR112015028853A2 (en) DETERGENT COMPOSITION WITH LOW PH
MX335107B (en) METHOD TO PROVIDE A LOW FRICTION SURFACE.
GT201200284A (en) PHARMACEUTICAL COMPOSITION
BRPI0919388A2 (en) succinic acid and method to produce the same.
BR112013019327A2 (en) compound and composition.
CO7000763A2 (en) Structured film containing beta-nucleating agent and method for making it
BR112013030546A2 (en) extrusion process.
CL2013000831A1 (en) Method for the determination of the allergen content of a composition.
FR2955770B1 (en) COSMETIC COMPOSITION.
BR112014013354A2 (en) process for the preparation of a polymer, composition, compound, and formulation
CL2014003055A1 (en) Process for preparing a pharmaceutical composition comprising i) providing a first combination comprising a peptide proteasome inhibitor compound, one or more cyclodextrins and water, and ii) contacting the first combination with an acid to form a second combination; pharmaceutical composition
BRPI0925100A2 (en) osmotic dosage form and process for preparing an osmotic dosage form
BR112013031575A2 (en) cyclic peptide compound of main structure, pharmaceutical composition, use of compound, and process for the manufacture of a compound.
DK2326638T3 (en) DIAZEPIN AND DIAZOCAN COMPOUNDS AS MC4 AGONISTS
IT1400714B1 (en) PROCESS AND INTERMEDIATE FOR THE PREPARATION OF AN ACTIVE PRINCIPLE.
BR112013030897A2 (en) composition.